Joachim Koch
Company: Affimed GmbH
Job title: Senior Director, Head Translational Research & Innovation
Seminars:
A Multipronged Approach to Activating the Power of the Innate Immune System: Innate Cell Engagers Monotherapy or in Combination with Other Agents 9:00 am
Demonstrating the growing body of evidence that innate cell engagement provides new therapeutic options for patients in need Sharing new data of Affimed’s Innate Cell Engagers (ICE® molecules) AFM13, AFM24 and AFM28 Outlining the three-pronged approach with the ICE® as monotherapy, or in combination with NK cell products or checkpoint inhibitorsRead more
day: Day Two
Panel Discussion & Roundtable: Achieving Success as a Field – How Can Cell Engagers Stand Out in a Competitive Landscape? 12:15 pm
The Cell Engager Summit is in it’s 4th year – it is therefore key that drug developers take note of the field’s progress and the hurdles that still lie ahead. Here we will ask: What are the current challenges of the field? Which key parameters can be used to determine what is truly working within…Read more
day: Day One